HRT FINANCIAL LP purchased $1.0M of BIAF
HRT FINANCIAL LP purchased 138,244 shares of bioAffinity Technologies, Inc. (BIAF) at an average of $7.52 ($6.54–$8.59, $1.04M total) across 11 trades over 2026-09-22 to 2026-10-01.
How this was made
The 30-second read
Why it matters
This provides a fresh, primary-source datapoint on ownership behavior, but it does not include new company fundamentals such as earnings, guidance, financing, or regulatory outcomes.
Market read
Traders may treat the filing as a modest sentiment input, but it is unlikely to drive a major repricing without accompanying fundamental catalysts.
What to watch
The trades occurred in late September to early October, so the market may have already partially priced any sentiment; also, no 10b5-1 plan is cited, which can cut both ways for interpretation.
Background
The article is an SEC Form 4 insider transaction disclosure: HRT Financial LP (10% owner) reported open-market purchases of bioAffinity Technologies, Inc. (BIAF).
Ticker impact
HRT Financial LP, a 10% owner, bought $1.04M of bioAffinity Technologies shares in open-market trades at $6.54 to $8.59 (avg $7.52).
Likely mild upward bias or support as traders interpret the purchase as confidence, though impact should be limited without guidance, earnings, or deal news.
The filing is a primary SEC Form 4 disclosure and the dollar amount is meaningful, but it is still an open-market purchase without stated strategic transaction terms or company-specific fundamentals.
Market effects
Minimal, as this is company-specific insider accumulation with no sector-wide regulatory or competitive signal.
None.
None.
Counterpoint
A large owner purchase can be driven by liquidity needs, diversification, or pre-existing intent rather than a forward-looking bullish thesis.
Key entities
- issuerbioAffinity Technologies, Inc.
Subject of the Form 4 insider purchase disclosure (BIAF).
- insiderHRT Financial LP
10% owner that purchased $1.04M of BIAF shares via open-market trades.

